SYRE
Spyre Therapeutics Inc.
88.20$
-4.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -23.9% | +12.5% | -25.3% | -100.0% | – | – | -87.6% | -62.0% | +0.0% | -100.0% | |
| – | +368.4% | – | – | – | – | +80.2% | +23.2% | -1.8% | -50.9% | +0.0% | +17,706.3% | |
| – | – | -22.8% | +12.5% | -25.3% | -123.2% | – | – | -87.6% | -103.3% | – | -19,473.9% | |
| – | +67.7% | +58.4% | +25.8% | +60.9% | +75.9% | -7.7% | -4.3% | +2.6% | +52.8% | +81.9% | +5.4% | |
| – | – | – | – | – | – | +22.7% | +25.1% | +4.4% | +40.0% | +14.6% | +4.7% | |
| – | +95.8% | +52.5% | +23.9% | +50.1% | +61.0% | +0.5% | +5.7% | +3.2% | +179.2% | -14.2% | -81.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -196.5% | – | – | -129.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.